PGF and fetal growth restriction: A recent study showed that adverse pregnancy outcomes such as intrauterine growth restriction (IUGR), placenta praevia, abruptio placenta, stillbirth and post-partum haemorrhage (PPH) were associated with an increased serum levels of soluble fms-like tyrosine kinas (sFlt-1), 8-epiprostaglandinF2-alpha (8epi-PGF2α) and a corresponding decreased levels of placental growth factor (PlGF) and total antioxidant capacity (TAC) preeclamptic births [12].